Charles River And Autobahn Labs Establish Partnership To Accelerate Academic Discoveries Into Novel Therapeutics; Charles River To Make Equity Investment In Autobahn Labs; Chief Scientific Officer Justin Bryans Named To Autobahn's Board Of Directors
- Agreement establishes Charles River as the preferred partner for Autobahn Labs, leveraging drug discovery and development capabilities to accelerate the translation of academic discoveries into novel therapeutics
- Under the agreement, Charles River will make an equity investment in Autobahn Labs
- Justin Bryans, Chief Scientific Officer, Discovery at Charles River, named to Autobahn's Board of Directors